Adele Rike-Shields

5PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsRegenerative medicine (incl. stem cells)Transplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 11, 2024
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations.

Nicole K Wilson, Simon Tremblay, Adele R Shields

|Jul 08, 2021
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.

Dixon B Kaufman, E Steve Woodle, Adele Rike Shields

|Nov 05, 2019
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.

E Steve Woodle, Dixon B Kaufman, Adele R Shields

|Sep 25, 2019
A prospective, iterative, adaptive trial of carfilzomib-based desensitization.

Simon Tremblay, James J Driscoll, Adele Rike-Shields

Pageof 1